Consultative body to discuss bioequivalence of combined preparations

The government plans to set up a consultative body consisting of representatives from industry, pharmaceutical and medical camps next January to discuss the controversial issue on bioequivalence of combined preparations.

The Korea Food and Drug Administration has reaffirmed that generic drugs of more two ingredients produced cheaply in Korea must prove they are equivalent to the patented med...